Você é um Profissional de Saúde? Clique aqui para fazer seu login e saber mais informações sobre este produto.
It was described in the first instance by the botanist Plunet in 1696 and later in the 18th century by Linnaeus. North American natives employed with low frequency in the form of poultice to treat snake bites. In 1828 it was incorporated into medical practice being a favorite for Turner’s physiomedical school. In 1860 it is finally taken to Europe. The activity of Cimicifuga is shown in studies with standardized extract at 2.5% of total triterpene glycosides (including 27-deoxiacteína, actein and cimicifugoside). 1 . Its traditionalism is based on 40 years of clinical experience as well as in investigations that have proven it effective in the relief of symptoms related to menopause. Considering that there are women who cannot use estrogen, there is a need to be able to administer a substitution treatment, without its side effects. Cimicifuga is a good option for women who are approaching menopause, especially for those concerned about the potential risks of conventional Hormone Replacement Therapy (HRT). Research suggests that HRT may increase health problems, including breast and endometrial cancer, gallbladder disease, abnormal vaginal bleeding, depression, weight gain, nausea, and headache. Currently, over a million and a half of European citizens consume Cimicifuga extracts with the purpose of alleviating hot flashes and depressive states. 2.3
Referências: 1 - Struck D, Tegtmeier M, Harnischfeger G. Flavones in extracts of Cimicifuga racemosa. Planta Med .63:289-290.1997. 2 - Farnsworth et al. The University of Illinois at Chicago/National Institutes of Health Center for Botanical Dietary Supplements Research for Women's Health: from plant to clinical use. Am J Clin Nutrr. 87(2): 504-8. 2008. 3 - Mello NK. Commentary on Black Cohosh for Treatment of Menopausal Disorders. Menopause. 2008; 15(5): 819-820.